… ProQR Announces Conference Presentations for Axiomer® RNA Editing Technology and QR-313 for DEB LEIDEN, … 2018 Conference ProQR will deliver a presentation on the Axiomer ® RNA editing technology during the TIDES: …
… ProQR Presents in vivo Proof of Concept Data for the Axiomer® RNA Editing Platform Technology Key updates ProQR … (Nasdaq:PRQR), today announced that a presentation titled “Axiomer ® Technology: Therapeutic Oligonucleotides for …
… Dr. Peter A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-I Editing Technology Key Updates Dr. Peter … in advancing the company’s novel and proprietary Axiomer ® RNA editing technology. The board now consists of …
… During the event, ProQR will highlight its proprietary Axiomer™ ADAR-mediated RNA editing platform, along with … diseases to prevent the need for transplantation About Axiomer ™ ProQR is pioneering a next-generation RNA base …
… momentum toward the clinic Accelerated development of Axiomer™ for CNS applications via new research partnership … on RNA editing, ProQR made important progress with Axiomer, our ADAR-mediated RNA editing technology platform,” …
… transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the … appointments support the advancement of the Company’s Axiomer platform technology and pipeline of RNA editing …
… transformative RNA therapies based on its proprietary Axiomer ™ RNA editing technology platform, today reported its … ProQR and further supports the confidence we have in our Axiomer technology,” said Daniel A. de Boer, Founder and CEO … with meaningful changes in biomarkers in NHPs using Axiomer™ RNA Editing Oligonucleotides. Key data reported …
… directed toward high conviction targets utilizing ProQR’s Axiomer technology INDIANAPOLIS; LEIDEN, Netherlands; and … announced in September 2021, applied ProQR’s proprietary Axiomer® RNA editing platform to target disorders of the …
… transformative RNA therapies based on its proprietary Axiomer ™ RNA editing technology platform, today reported its … at the RNA Editing Summit in Boston, highlighting its Axiomer technology platform and AX-0810, the Company’s … with meaningful changes in biomarkers in NHPs using Axiomer RNA Editing Oligonucleotides. At ASGCT, ProQR and …